Crossmark Global Holdings Inc. Acquires 1,367 Shares of Smith & Nephew plc (NYSE:SNN)

Crossmark Global Holdings Inc. increased its holdings in shares of Smith & Nephew plc (NYSE:SNN) by 1.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 114,226 shares of the medical equipment provider’s stock after acquiring an additional 1,367 shares during the period. Crossmark Global Holdings Inc.’s holdings in Smith & Nephew were worth $2,808,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the business. EverSource Wealth Advisors LLC lifted its position in shares of Smith & Nephew by 92.5% during the second quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock worth $61,000 after purchasing an additional 1,179 shares during the last quarter. GAMMA Investing LLC boosted its position in Smith & Nephew by 160.0% in the 3rd quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock valued at $70,000 after buying an additional 1,389 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Smith & Nephew by 74.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,025 shares of the medical equipment provider’s stock worth $94,000 after acquiring an additional 1,290 shares in the last quarter. Blue Trust Inc. increased its position in shares of Smith & Nephew by 460.5% during the third quarter. Blue Trust Inc. now owns 4,658 shares of the medical equipment provider’s stock worth $145,000 after acquiring an additional 3,827 shares during the period. Finally, Coerente Capital Management bought a new stake in shares of Smith & Nephew during the third quarter valued at approximately $202,000. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on SNN shares. StockNews.com lowered shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 12th. Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Finally, Berenberg Bank cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th.

Smith & Nephew Trading Down 2.1 %

Shares of SNN opened at $25.18 on Thursday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. Smith & Nephew plc has a 52 week low of $23.65 and a 52 week high of $31.72. The stock’s 50-day moving average price is $25.01 and its 200-day moving average price is $27.78.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.